TURK İLAÇ VE SERUM SANAYİ A.Ş. Logo

TURK İLAÇ VE SERUM SANAYİ A.Ş.

Turkish producer of pharmaceuticals, specializing in IV solutions and vaccines for hospitals.

TRILC | IS

Overview

Corporate Details

ISIN(s):
TRETRLC00014 (+1 more)
LEI:
78900003BNEUMO8X3Y93
Country:
Türkiye
Address:
BÜĞDÜZ MAH. ENVER PAŞA CAD. NO: 8 AKYURT / ANKARA, 06750 ANKARA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Turk İlaç ve Serum Sanayi A.Ş. is a pharmaceutical company specializing in the production of human medicines. The company operates Turkey's highest-capacity IV parenteral solution (serum) production facility and is a major supplier to the country's public and private hospitals. A pioneer in domestic vaccine manufacturing, it established Turkey's first private vaccine production plant. Its portfolio also includes a range of other pharmaceuticals such as tablets, capsules, ampoules, and vials, all produced in its integrated, GMP-compliant facilities.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-25 14:55
Capital/Financing Update
Borçlanma Aracı İhracı Hakkında
English 17.9 KB
2025-09-22 22:36
Capital/Financing Update
Borçlanma Aracı İhraç Belgesi
Turkish 4.6 MB
2025-09-22 22:36
Capital/Financing Update
Borçlanma Aracı İhraç Belgesi
Turkish 15.2 KB
2025-09-19 21:38
Regulatory News Service
Borçlanma Aracı İhraç Tavanının SPK Tarafından Onaylanması
Turkish 5.4 KB
2025-09-03 17:47
Capital/Financing Update
Borçlanma Aracı İhracına İlişkin Yönetim Kurulu Kararı Alınması
Turkish 4.9 KB
2025-08-20 08:58
Regulatory News Service
Türkmenİstan Sağlık ve İlaç Bakanlığı ile imzalanan Sözleşmenin Sevkiyatlarının…
Turkish 17.8 KB
2025-08-18 20:29
Interim Report
Participation Finance Principles Information Form
English 52.6 KB
2025-08-13 09:08
Regulatory News Service
DMO İhale Sonucu Hakkında
English 42.1 KB
2025-08-11 18:29
Interim Report
Sorumluluk Beyanı
Turkish 20.4 KB
2025-08-11 18:29
Regulatory News Service
Financial Report
Turkish 2.0 MB
2025-08-11 18:29
Annual / Quarterly Financial Statement
Financial Report
English 2.5 MB
2025-08-11 18:29
Regulatory News Service
Faaliyet Raporu
Turkish 2.5 MB
2025-08-11 18:29
Report Publication Announcement
Faaliyet Raporu
English 11.0 KB
2025-08-04 14:36
Capital/Financing Update
Finansman Bonosu İtfası Hakkında
English 18.0 KB
2025-08-04 08:24
Capital/Financing Update
Satışın Tamamlanması Hakkında
English 18.2 KB

Automate Your Workflow. Get a real-time feed of all TURK İLAÇ VE SERUM SANAYİ A.Ş. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for TURK İLAÇ VE SERUM SANAYİ A.Ş. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.